Aju Ib Investment Co 13F annual report
Aju Ib Investment Co is an investment fund managing more than $58.4 million ran by Jiyong Choe. There are currently 7 companies in Choe’s portfolio. The largest investments include Arcellx Inc and Rallybio Corp, together worth $36.8 million.
$58.4 million Assets Under Management (AUM)
As of 7th November 2022, Aju Ib Investment Co’s top holding is 1,380,890 shares of Arcellx Inc currently worth over $25.9 million and making up 44.4% of the portfolio value.
In addition, the fund holds 754,678 shares of Rallybio Corp worth $10.9 million.
The third-largest holding is Kymera Therapeutics worth $9.95 million and the next is Seer worth $6.32 million, with 816,375 shares owned.
Currently, Aju Ib Investment Co's portfolio is worth at least $58.4 million. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Aju Ib Investment Co
The Aju Ib Investment Co office and employees reside in Seoul, Korea, Republic Of. According to the last 13-F report filed with the SEC, Jiyong Choe serves as the Compliance Team Manager at Aju Ib Investment Co.
One of the smallest hedge funds
The two most similar investment funds to Aju Ib Investment Co are Corbett Road Capital Management and Scoggin Management L.P.. They manage $58.4 million and $58.4 million respectively.
Jiyong Choe investment strategy
Aju Ib Investment Co’s portfolio is diversified across 2 sectors.
Currently, their heaviest sector is Health Care — making up 33.6% of
the total portfolio value.
The fund focuses on investments in the United States as
57.1% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
approximately 0.1% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $792 million.
The complete list of Aju Ib Investment Co trades based on 13F SEC filings
These positions were updated on November 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Arcellx Inc |
No change
1,380,890
|
$25,919,000 | 44.37% |
| Rallybio Corp |
No change
754,678
|
$10,920,000 | 18.69% |
| Kymera Therapeutics, Inc. |
No change
457,059
|
$9,950,000 | 17.03% |
| Seer, Inc. |
No change
816,375
|
$6,319,000 | 10.82% |
| RAPT Therapeutics, Inc. |
No change
99,503
|
$2,394,000 | 4.10% |
| Xilio Therapeutics Inc |
No change
667,742
|
$1,943,000 | 3.33% |
| Sutro Biopharma Inc |
No change
175,000
|
$971,000 | 1.66% |
| No transactions found | |||
| Showing first 500 out of 7 holdings | |||
Hedge funds similar to Aju Ib Investment Co
- Bluemountain Capital Management
- First National Bank Of Chester County
- Bailey Value Limited Partnership
- Optima Fund Management
- Avenir Management
- Chesapeake Asset Management
- Corbett Road Capital Management
- Scoggin Management L.P.
- Lockheed Martin Corp
- Connective Portfolio Management
- Plan
- New Vernon Investment Management
- Asia Research & Capital Management Ltd
- Accomplice Associates Ii